Wojciech S, Agnieszka P, Piotr S, et al. Somatic embryogenesis and in vitro culture of Huperzia selago.shoots as a potential source of huperzine A[J]. Plant Sci, 2005,168:1443.
[13]
Ma X Q, Gang D R. In vitro production of huperzine A, a promising drug candidate for Alzheimer\'s disease[J]. Phytochemistry, 2008,69:2022.
Hartving P, Wiklund L, Aquilonius S M, et al. Clinical pharmacokinetics of centrally acting cholinesteraee inhibitors[M]//Becker R, Giacobini E, eds. Cholinergic basis for Alzheimer therapy. Boston: Birkhauser, 1991:68.
[25]
Raves M L, Harel M, Pang Y P, et al. Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A[J]. Nat Struct Biol, 1997,4:57.
[26]
Zhao Q, Tang X C. Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparion with tacine, donepezil, rivastigmine and physostigmine[J]. Eur J Pharmacol, 2002,455:101.
[27]
Skolnick A A. Old Chinese herbal medicine used for fever yields possible new Alzheimer disease therapy[J]. J Am Med Assoc, 1997,277:776.
Wang R, Tang X C. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer\'s disease[J]. Neurosignals, 2005,14:71.